Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Mosier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Orthopaedics and Related Research|January 11, 2000
Pathoanatomy and etiology of posterior tibial tendon dysfunctionS M Mosier, G Pomeroy, A Manoli
Foot & Ankle International|September 5, 1998
Pathology of the posterior tibial tendon in posterior tibial tendon insufficiencyS M Mosier, D R Lucas, G Pomeroy, et al.
The Journal of Clinical Investigation|September 1, 1995
Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infectionB Rehermann, C Pasquinelli, S M Mosier, et al.
Foot & Ankle International|June 1, 2000
Medial impingement syndrome of the anterior tibiotalar fascicle of the deltoid ligament on the talusS M Mosier-La Clair, M T Monroe, A Manoli
Endocrinology|January 1, 1993
Loss of lutropin/human choriogonadotropin receptor messenger ribonucleic acid during ligand-induced down-regulation occurs post transcriptionallyD L Lu, H Peegel, S M Mosier, et al.
Virology|March 30, 2001
Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenicG Dollenmaier, S M Mosier, F Scholle, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41L Xu, A Pozniak, A Wildfire, et al.
Journal of Virology|September 15, 2005
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitroM Mink, S M Mosier, S Janumpalli, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Orthopaedics and Related Research|January 11, 2000
Pathoanatomy and etiology of posterior tibial tendon dysfunctionS M Mosier, G Pomeroy, A Manoli
Foot & Ankle International|September 5, 1998
Pathology of the posterior tibial tendon in posterior tibial tendon insufficiencyS M Mosier, D R Lucas, G Pomeroy, et al.
The Journal of Clinical Investigation|September 1, 1995
Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infectionB Rehermann, C Pasquinelli, S M Mosier, et al.
Foot & Ankle International|June 1, 2000
Medial impingement syndrome of the anterior tibiotalar fascicle of the deltoid ligament on the talusS M Mosier-La Clair, M T Monroe, A Manoli
Endocrinology|January 1, 1993
Loss of lutropin/human choriogonadotropin receptor messenger ribonucleic acid during ligand-induced down-regulation occurs post transcriptionallyD L Lu, H Peegel, S M Mosier, et al.
Virology|March 30, 2001
Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenicG Dollenmaier, S M Mosier, F Scholle, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41L Xu, A Pozniak, A Wildfire, et al.
Journal of Virology|September 15, 2005
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitroM Mink, S M Mosier, S Janumpalli, et al.
Pageof 1